Stifel Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
28,981
+10,133
+54% +$714K ﹤0.01% 2011
2025
Q4
$1.27M Buy
18,848
+1,444
+8% +$97.1K ﹤0.01% 2279
2025
Q3
$1.28M Buy
17,404
+148
+0.9% +$9.83K ﹤0.01% 2230
2025
Q2
$898K Sell
17,256
-4,800
-22% -$273K ﹤0.01% 2401
2025
Q1
$1.41M Sell
22,056
-8,712
-28% -$506K ﹤0.01% 2006
2024
Q4
$1.47M Buy
30,768
+13,647
+80% +$700K ﹤0.01% 1994
2024
Q3
$980K Buy
17,121
+9,555
+126% +$548K ﹤0.01% 2242
2024
Q2
$396K Buy
7,566
+433
+6% +$19K ﹤0.01% 2767
2024
Q1
$290K Buy
+7,133
New +$267K ﹤0.01% 2936
2021
Q4
Sell
-13,476
Closed -$548K 3399
2021
Q3
$548K Sell
13,476
-474
-3% -$19.8K ﹤0.01% 2530
2021
Q2
$633K Buy
13,950
+1,081
+8% +$47.8K ﹤0.01% 2438
2021
Q1
$537K Buy
+12,869
New +$588K ﹤0.01% 2440
2017
Q2
Sell
-14,600
Closed -$187K 2583
2017
Q1
$187K Buy
+14,600
New +$185K ﹤0.01% 2344
2016
Q4
Sell
-22,172
Closed -$269K 2506
2016
Q3
$269K Buy
22,172
+2,389
+12% +$24.4K ﹤0.01% 2035
2016
Q2
$171K Sell
19,783
-5,033
-20% -$49.7K ﹤0.01% 2294
2016
Q1
$235K Buy
24,816
+2,288
+10% +$21.5K ﹤0.01% 1936
2015
Q4
$390K Buy
22,528
+7,528
+50% +$120K ﹤0.01% 1783
2015
Q3
$201K Sell
15,000
-9,500
-39% -$191K ﹤0.01% 2026
2015
Q2
$553K Sell
24,500
-11,000
-31% -$193K ﹤0.01% 1632
2015
Q1
$507K Buy
35,500
+500
+1% +$7.21K ﹤0.01% 1619
2014
Q4
$338K Hold
35,000
﹤0.01% 1804
2014
Q3
$319K Hold
35,000
﹤0.01% 1766
2014
Q2
$346K Buy
35,000
+1,100
+3% +$9.33K ﹤0.01% 1702
2014
Q1
$431K Buy
+33,900
New +$503K ﹤0.01% 1506

Other funds holding HALO

Stifel Financial's HALO Position: Q1 2026 in Review

Stifel Financial increased its Halozyme (HALO) stake by 54% in Q1 2026, buying an estimated $714K and bringing the position to 28,981 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Stifel Financial first reported a position in HALO in Q1 2014 and has held it in 24 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Stifel Financial held 28,981 shares of Halozyme worth $1.87M as of Q1 2026.
  • Stifel Financial bought 10,133 Halozyme shares in Q1 2026, an estimated $714K.
  • Halozyme made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2011 holding.
  • Stifel Financial first reported a position in Halozyme in Q1 2014 and has held it in 24 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.